Quantum biochemistry description of PI3Kα enzyme bound to selective inhibitors

被引:0
|
作者
de Sousa, Francisca Joseli Freitas [1 ]
Azevedo, Francisca Fernanda Nunes [1 ]
de Oliveira, Francisco Lucas Santos [2 ]
Carletti, Jaqueline Vieira [3 ]
Freire, Valder Nogueira [4 ]
Zanatta, Geancarlo [1 ,2 ]
机构
[1] Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Brazil
[2] Univ Fed Rio Grande do Sul, Dept Biophys, Porto Alegre, Brazil
[3] Univ Fed Rio Grande do Sul, Dept Biochem, Porto Alegre, Brazil
[4] Univ Fed Ceara, Dept Phys, Fortaleza, Brazil
关键词
Alpelisib; GDC-0326; PI3K alpha-inhibitors; phosphoinositide-3-kinase; molecular fragmentation with conjugated caps; quantum calculation; POPULATION ANALYSIS; INFORMATION-THEORY; ISOFORM; IDENTIFICATION; MECHANICS; BINDING; DESIGN; NVP-BYL719; MOLECULES; DISCOVERY;
D O I
10.1080/07391102.2023.2251063
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The PI3K class I is composed of four PI3K isoforms that serve as regulatory enzymes governing cellular metabolism, proliferation, and survival. The hyperactivation of PI3K alpha is observed in various types of cancer and is linked to poor prognosis. Unfortunately, the development inhibitors selectively targeting one of the isoforms remains challenging, with only few agents in clinical use. The main difficulty arises from the high conservation among residues at the ATP-binding pocket across isoforms, which also serves as target pocket for inhibitors. In this work, molecular dynamics and quantum calculations were performed to investigate the molecular features guiding the binding of selective inhibitors, alpelisib and GDC-0326, into the ATP-binding pocket of PI3K alpha. While molecular dynamics allowed crystallographic coordinates to relax, the interaction eergy between each amino acid residues and inhibitors was obtained by combining the Molecular Fractionation with Conjugated Caps scheme with Density Functional Theory calculations. In addition, the atomic charge of ligands in the bound and unbound (free) was calculated. Results indicated that the most relevant residues for the binding of alpelisib are Ile932, Glu859, Val851, Val850, Tyr836, Met922, Ile800, and Ile848, while the most important residues for the binding of GDC-0326 are Ile848, Ile800, Ile932, Gln859, Glu849, and Met922. In addition, residues Trp780, Ile800, Tyr836, Ile848, Gln859 Val850, Val851, Ile932 and Met922 are common hotspots for both inhibitors. Overall, the results from this work contribute to improving the understanding of the molecular mechanisms controlling selectivity and highlight important interactions to be considered during the rational design of new agents.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Selective PI3K and dual PI3K/mTOR inhibitors enhance the efficacy of endocrine therapies in breast cancer models
    Friedman, L.
    Ross, L. B.
    Wallin, J.
    Guan, J.
    Prior, W. W.
    Wu, E.
    Nannini, M.
    Sampath, D.
    [J]. CANCER RESEARCH, 2012, 72
  • [32] Pharmacokinetics of selective PI3Kδ inhibitors after intratracheal instillation in mice
    Gunerka, Pawel
    Hucz-Kalitowska, Joanna
    Turowski, Pawel
    Zagozda, Marcin
    Dziachan, Maciej
    Sekular, Mariola
    Bujak, Anna
    Wieczorek, Maciej
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [33] Preclinical profile of novel, potent, and selective PI3K delta inhibitors
    Vakkalanka, Swaroop
    Muthuppalaniappan, Meyyappan
    Babu, G.
    Varanasi, Kanthikiran V. S.
    Veeraraghavan, Sridhar
    Viswanadha, Srikant
    [J]. CANCER RESEARCH, 2011, 71
  • [34] Discovery and optimization of heteroaryl piperazines as potent and selective PI3Kδ inhibitors
    Zhou, Hua
    McGowan, Meredeth A.
    Lipford, Kathryn
    Christopher, Matthew
    Fradera, Xavier
    Witter, David
    Lesburg, Charles A.
    Li, Chaomin
    Methot, Joey L.
    Lampe, John
    Achab, Abdelghani
    Shaffer, Lynsey
    Goldenblatt, Peter
    Shah, Sanjiv
    Bass, Alan
    Schroeder, Gottfried
    Chen, Dapeng
    Zeng, Haoyu
    Augustin, Martin A.
    Katz, Jason D.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (01)
  • [35] A class of highly selective inhibitors bind to an active state of PI3Kγ
    Gangadhara, Gangadhara
    Dahl, Goran
    Bohnacker, Thomas
    Rae, Rebecca
    Gunnarsson, Jenny
    Blaho, Stefan
    Oster, Linda
    Lindmark, Helena
    Karabelas, Kostas
    Pemberton, Nils
    Tyrchan, Christian
    Mogemark, Mickael
    Wymann, Matthias P.
    Williams, Roger L.
    Perry, Matthew W. D.
    Papavoine, Tineke
    Petersen, Jens
    [J]. NATURE CHEMICAL BIOLOGY, 2019, 15 (04) : 348 - +
  • [36] Discovery and Optimization of Pyridazinones as PI3Kδ Selective Inhibitors for Administration by Inhalation
    Bruno, Paolo
    Micoli, Alessandra
    Corsi, Mauro
    Pala, Daniele
    Guariento, Sara
    Fiorelli, Claudio
    Ronchi, Paolo
    Fioni, Alessandro
    Gallo, Paola Maria
    Marenghi, Giulia
    Bertolini, Serena
    Capacchi, Silvia
    Mileo, Valentina
    Biagetti, Matteo
    Capelli, Anna Maria
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2024,
  • [37] A class of highly selective inhibitors bind to an active state of PI3Kγ
    Gangadhara Gangadhara
    Göran Dahl
    Thomas Bohnacker
    Rebecca Rae
    Jenny Gunnarsson
    Stefan Blaho
    Linda Öster
    Helena Lindmark
    Kostas Karabelas
    Nils Pemberton
    Christian Tyrchan
    Mickael Mogemark
    Matthias P. Wymann
    Roger L. Williams
    Matthew W. D. Perry
    Tineke Papavoine
    Jens Petersen
    [J]. Nature Chemical Biology, 2019, 15 : 348 - 357
  • [38] PI3K Inhibitors in Cardiovascular Disease
    Eisenreich, Andreas
    Rauch, Ursula
    [J]. CARDIOVASCULAR THERAPEUTICS, 2011, 29 (01) : 29 - 36
  • [39] Horizons broaden for PI3Kδ inhibitors
    Katie Kingwell
    [J]. Nature Reviews Drug Discovery, 2014, 13 : 573 - 573
  • [40] Novel inhibitors of the PI3K family
    Carnero, Amancio
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (09) : 1265 - 1277